AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32128938 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness uncertainty through avoidant coping strategies
Number of subjects: 263
Study 35442755 — intervention group
Group type: EXPERIMENTAL
Intervention: ET with ibandronate 50 mg once daily for 3 years
Number of subjects: 1116
Study 35442755 — intervention group
Group type: COMPARATOR
Intervention: ET alone (control)
Number of subjects: 1116
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ag NPs at 15 mL/L
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ag NPs at 12.5 mL/L
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn NPs at 7.5 mL/L
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ag NPs
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn NPs
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ag NPs treated leaves extract at 3000 µg/mL
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone extracts from leaves treated with Ag NPs
Number of subjects: 70
Study 33986453 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone extracts from leaves treated with both nanomaterials
Number of subjects: 70
Study 33986453 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 70
Study 32418039 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 83
Study 32418039 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin (CsA)
Number of subjects: 83
Study 34301673 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender transformative intervention (10-session participatory intervention)
Number of subjects: 1265
Study 33538513 — intervention group
Group type: EXPERIMENTAL
Intervention: Instagram image sharing
Number of subjects: 106
Study 35564623 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability Biofeedback (HRVBFB) plus Treatment as Usual (TAU)
Number of subjects: 61
Study 35564623 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) only
Number of subjects: 61
Study 34357722 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulatory drug based on muramilpeptides
Number of subjects: 20
Study 34357722 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with no muramilpeptides‐based agent
Number of subjects: 20
Study 32087620 — intervention group
Group type: EXPERIMENTAL
Intervention: PSI group (TKA assisted by patient-specific instrumentation)
Number of subjects: 80
Study 32087620 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (conventional TKA)
Number of subjects: 80
Study 32087620 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 35405100 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic compression stockings (ECS) with 25-30 mm Hg pressure
Number of subjects: 268
Study 35405100 — intervention group
Group type: COMPARATOR
Intervention: Sham elastic compression stockings (≤10 mm Hg pressure)
Number of subjects: 268
Study 33760035 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of remnant cholesterol (quartile 4)
Number of subjects: 3812
Study 32242541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (9-month duration) including weekly classroom education, after-school cooking classes, and online materials
Number of subjects: 229
Study 32242541 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention
Number of subjects: 229
Study 32242541 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 229
Study 35710336 — intervention group
Group type: EXPERIMENTAL
Intervention: REACH-HF intervention at Beacon Sites
Number of subjects: 0
Study 35710336 — intervention group
Group type: COMPARATOR
Intervention: REACH-HF multicentre trial
Number of subjects: 0
Study 35103343 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole pulse therapy
Number of subjects: 135
Study 35103343 — intervention group
Group type: COMPARATOR
Intervention: Acitretin
Number of subjects: 135
Study 35103343 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined itraconazole/acitretin therapy
Number of subjects: 135
Study 32324898 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir
Number of subjects: 217
Study 32324898 — intervention group
Group type: EXPERIMENTAL
Intervention: Umifenovir
Number of subjects: 217
Study 32324898 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 217
Study 32324898 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of stay
Number of subjects: 217
Study 32324898 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of drugs used in the hospital
Number of subjects: 217
Study 32324898 — intervention group
Group type: EXPERIMENTAL
Intervention: Underlying basic diseases
Number of subjects: 217
Study 35986372 — intervention group
Group type: EXPERIMENTAL
Intervention: Early essential newborn care (EENC) with skin-to-skin contact for 30 min
Number of subjects: 720
Study 35986372 — intervention group
Group type: EXPERIMENTAL
Intervention: Early essential newborn care (EENC) with skin-to-skin contact for 60 min
Number of subjects: 720
Study 35986372 — intervention group
Group type: EXPERIMENTAL
Intervention: Early essential newborn care (EENC) with skin-to-skin contact for 90 min
Number of subjects: 720
Study 35986372 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 720
Study 34900605 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored internet-based intervention (IBI) program
Number of subjects: 360
Study 34900605 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 360
Study 36657487 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline number of chronic diseases
Number of subjects: 2157
Study 36657487 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline multimorbidity (3 or more chronic diseases)
Number of subjects: 2157
Study 33504021 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTN3 R577X genotype in men
Number of subjects: 281
Study 33504021 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTN3 R577X genotype in women
Number of subjects: 281
Study 36318852 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatilen AC (Zinc arginyle-glycinate dihydrochloride)
Number of subjects: 98
Study 36318852 — intervention group
Group type: COMPARATOR
Intervention: Prostatilen (reference drug)
Number of subjects: 98
Study 36318852 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatilen AC
Number of subjects: 98
Study 36318852 — intervention group
Group type: COMPARATOR
Intervention: Prostatilen
Number of subjects: 98
Study 34217337 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride solution
Number of subjects: 480
Study 34217337 — intervention group
Group type: COMPARATOR
Intervention: Plasma‐Lyte 148
Number of subjects: 480
Study 34217337 — intervention group
Group type: COMPARATOR
Intervention: Compound Sodium Lactate
Number of subjects: 480
Study 34096389 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided method
Number of subjects: 50
Study 34096389 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 50
Study 36217147 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation (RDI)
Number of subjects: 93
Study 36217147 — intervention group
Group type: COMPARATOR
Intervention: Cotton roll isolation (CRI)
Number of subjects: 93
Study 32269026 — intervention group
Group type: EXPERIMENTAL
Intervention: Online video series with sexual health information via pamphlet
Number of subjects: 300
Study 32269026 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet with sexual health information only
Number of subjects: 300
Study 34229475 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief manual standardized stress acupuncture (MSSA) combined with abbreviated Cognitive Behavioral Therapy (ACBT)
Number of subjects: 0
Study 34229475 — intervention group
Group type: COMPARATOR
Intervention: ACBT alone
Number of subjects: 0
Study 32718191 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough (SD) bread
Number of subjects: 17
Study 32718191 — intervention group
Group type: EXPERIMENTAL
Intervention: Baker's yeast (BY) bread
Number of subjects: 17
Study 33105552 — intervention group
Group type: EXPERIMENTAL
Intervention: GluS (Glutathione Synthesis)
Number of subjects: 2
Study 33105552 — intervention group
Group type: EXPERIMENTAL
Intervention: GluReS (Glutathione and Resveratrol Synthesis)
Number of subjects: 2
Study 34607760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided serratus anterior plane block (SAPB)
Number of subjects: 70
Study 34607760 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SAPB)
Number of subjects: 70
Study 33764299 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 0
Study 33764299 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study 33764299 — intervention group
Group type: EXPERIMENTAL
Intervention: Social condition
Number of subjects: 0
Study 33764299 — intervention group
Group type: COMPARATOR
Intervention: Unavailable and unresponsive conditions
Number of subjects: 0
Study 32722659 — intervention group
Group type: EXPERIMENTAL
Intervention: MR stimulation (fludrocortisone 0.4 mg + placebo)
Number of subjects: 232
Study 32722659 — intervention group
Group type: EXPERIMENTAL
Intervention: NMDA-R stimulation (placebo + D-cycloserine 250 mg)
Number of subjects: 232
Study 32722659 — intervention group
Group type: EXPERIMENTAL
Intervention: MR and NMDA-R stimulation (both drugs)
Number of subjects: 232
Study 32722659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study 35574927 — intervention group
Group type: EXPERIMENTAL
Intervention: True bilateral cerebellar iTBS
Number of subjects: 70
Study 35574927 — intervention group
Group type: COMPARATOR
Intervention: Sham bilateral cerebellar iTBS
Number of subjects: 70
Study 33030042 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week tinnitus-specific cognitive behavioral therapy (CBT) and personalized sound therapy via smartphone application
Number of subjects: 30
Study 33030042 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlisted patients)
Number of subjects: 30
Study 33030042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment and control groups
Number of subjects: 30
Study 35331009 — intervention group
Group type: EXPERIMENTAL
Intervention: Quarterly fremanezumab
Number of subjects: 2842
Study 35331009 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly fremanezumab
Number of subjects: 2842
Study 35331009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2842
Study 32018189 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (mean duration 6.60 hours/night)
Number of subjects: 8
Study 32018189 — intervention group
Group type: COMPARATOR
Intervention: Habitual sleep (mean duration 5.58 hours/night)
Number of subjects: 8
Study 32018189 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher sleep efficiency
Number of subjects: 8
Study 35815489 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐bent Kirschner wire
Number of subjects: 32
Study 35815489 — intervention group
Group type: EXPERIMENTAL
Intervention: Prévot nail
Number of subjects: 32
Study 35815489 — intervention group
Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 32
Study 35815489 — intervention group
Group type: EXPERIMENTAL
Intervention: Kirschner wire
Number of subjects: 32
Study 33131786 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical mobilisations
Number of subjects: 40
Study 33131786 — intervention group
Group type: COMPARATOR
Intervention: Placebo (motionless manual contact)
Number of subjects: 40
Study 32605387 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with a defibrillator (CRT-D)
Number of subjects: 1818
Study 32605387 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator (ICD) only
Number of subjects: 1818
Study 35798455 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavacamten, 5 mg daily, titrated up to 15 mg based on LVOT gradient and LV ejection fraction
Number of subjects: 112
Study 35798455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 35798455 — intervention group
Group type: EXPERIMENTAL
Intervention: Mavacamten
Number of subjects: 112
Study 34312088 — intervention group
Group type: EXPERIMENTAL
Intervention: Long testosterone (12.5 mg/day testosterone gel for 56 days)
Number of subjects: 63
Study 34312088 — intervention group
Group type: EXPERIMENTAL
Intervention: Short testosterone (12.5 mg/day testosterone gel for 10 days)
Number of subjects: 63
Study 34312088 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 63
Study 34312088 — intervention group
Group type: EXPERIMENTAL
Intervention: Long testosterone
Number of subjects: 63
Study 34312088 — intervention group
Group type: EXPERIMENTAL
Intervention: Short testosterone
Number of subjects: 63
Study 34312088 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 63
Study 35356997 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine skin prick
Number of subjects: 60
Study 35356997 — intervention group
Group type: COMPARATOR
Intervention: Placebo skin prick
Number of subjects: 60
Study 33297402 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning methods based on a convolutional neural network and cost-effective computer vision technology
Number of subjects: 1240
Study 35341320 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells (MSCs) intravenous injection
Number of subjects: 54
Study 35341320 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 54
Study 33965945 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (≥180 s)
Number of subjects: 540
Study 33965945 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (≤60 s)
Number of subjects: 540
Study 32345275 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate health literacy
Number of subjects: 15728
Study 32345275 — intervention group
Group type: EXPERIMENTAL
Intervention: Problematic health literacy
Number of subjects: 15728
Study 32345275 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical inactivity
Number of subjects: 15728
Study 32345275 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 15728
Study 32345275 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor self-assessed health
Number of subjects: 15728
Study 32345275 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickness absence compensation benefits
Number of subjects: 15728
Study 33128533 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Motor Imagery (GMI)
Number of subjects: 11
Study 33128533 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 11
Study 33487261 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry extract of ginger (5% gingerol)
Number of subjects: 20
Study 33487261 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 20
Study 36407493 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanoemulsion oral solution (60,000 IU cholecalciferol)
Number of subjects: 24
Study 36407493 — intervention group
Group type: COMPARATOR
Intervention: Soft gelatin capsules (60,000 IU cholecalciferol)
Number of subjects: 24
Study 33580564 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (T) + Exercise (Ex)
Number of subjects: 0
Study 33580564 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone treatment (T)
Number of subjects: 0
Study 33580564 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) + Exercise (Ex)
Number of subjects: 0
Study 33580564 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (Ex)
Number of subjects: 0
Study 32459660 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction + feedback group
Number of subjects: 12
Study 32459660 — intervention group
Group type: COMPARATOR
Intervention: Instruction only group
Number of subjects: 12
Study 34252575 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance-based attentive rehabilitation of attention (BARAN)
Number of subjects: 29
Study 34252575 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise and running (active control)
Number of subjects: 29
Study 32510462 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month behavior change program via mobile app (TravelVu Plus)
Number of subjects: 254
Study 32510462 — intervention group
Group type: COMPARATOR
Intervention: Standard TravelVu app
Number of subjects: 254
Study 36413078 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored use of defunctioning stoma based on personalized risk of anastomotic leak (mAFOR Score >= 2) and early stoma closure (days 8-12 postoperatively)
Number of subjects: 200
Study 36413078 — intervention group
Group type: COMPARATOR
Intervention: Systematic use of defunctioning stoma for 2-3 months post-operatively
Number of subjects: 200
Study 36413078 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored use of defunctioning stoma
Number of subjects: 200
Study 36413078 — intervention group
Group type: COMPARATOR
Intervention: Systematic use of defunctioning stoma
Number of subjects: 200
Study 36413078 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 200
Study 32940823 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusive physical activity (IPA) program
Number of subjects: 45
Study 32066973 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-enriched salt substitute (75% NaCl and 25% KCl)
Number of subjects: 2376
Study 32066973 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-enriched salt substitute
Number of subjects: 2376
Study 32066973 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular salt)
Number of subjects: 2376
Study 34995745 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-hour simulation training
Number of subjects: 48
Study 34995745 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour simulation training
Number of subjects: 48
Study 34995745 — intervention group
Group type: COMPARATOR
Intervention: Vascular surgeons (control group)
Number of subjects: 48
Study 34733561 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy (12 sessions, twice a week for 6 weeks)
Number of subjects: 96
Study 34733561 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid injection (80 mg of methylprednisolone and 1 ml of lidocaine 2% in two stages, 21 days apart)
Number of subjects: 96
Study 34733561 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of physiotherapy and corticosteroid injection (80 mg of methylprednisolone and 1 ml of lidocaine 2%, followed by 6 sessions of physiotherapy twice a week for 3 weeks)
Number of subjects: 96
Study 35194862 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette starter pack with weekly allocations of nicotine containing e-liquid for 4 weeks (flavours: menthol, fruit, tobacco; strengths: 12 mg/mL and 18 mg/mL)
Number of subjects: 480
Study 35194862 — intervention group
Group type: COMPARATOR
Intervention: Usual care intervention (very brief advice and a leaflet signposting to the local stop smoking service)
Number of subjects: 480
Study 35194862 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette starter pack
Number of subjects: 480
Study 34113094 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nemiralisib (1mg) in stable COPD
Number of subjects: 72
Study 34113094 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nemiralisib (1mg) in AECOPD
Number of subjects: 72
Study 34113094 — intervention group
Group type: COMPARATOR
Intervention: Placebo in stable COPD
Number of subjects: 72
Study 34113094 — intervention group
Group type: COMPARATOR
Intervention: Placebo in AECOPD
Number of subjects: 72
Study 32265532 — intervention group
Group type: EXPERIMENTAL
Intervention: More years of schooling (including college)
Number of subjects: 0
Study 32265532 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intelligence
Number of subjects: 0
Study 32265532 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age of finishing school
Number of subjects: 0
Study 32265532 — intervention group
Group type: EXPERIMENTAL
Intervention: More years of schooling
Number of subjects: 0
Study 34542801 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult-associated BMI scores
Number of subjects: 194153
Study 34542801 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood-associated BMI scores
Number of subjects: 194153
Study 33226660 — intervention group
Group type: COMPARATOR
Intervention: WALK8 (8 minutes every 60 minutes)
Number of subjects: 16
Study 33226660 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (9 hours of prolonged sitting)
Number of subjects: 16
Study 33226660 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK3 (3 minutes of brisk walking every 30 minutes)
Number of subjects: 16
Study 33226660 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK5 (5 minutes of brisk walking every 45 minutes)
Number of subjects: 16
Study 33319866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon (0.1 mg kg-1 dissolved in 5 mL of lactose-containing syrup)
Number of subjects: 50
Study 33319866 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same amount of syrup alone)
Number of subjects: 50
Study 33319866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon
Number of subjects: 50
Study 33319866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34145479 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + PE
Number of subjects: 37
Study 34145479 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 37
Study 34306265 — intervention group
Group type: EXPERIMENTAL
Intervention: LABA + inhaled corticosteroid (formoterol/budesonide)
Number of subjects: 45
Study 34306265 — intervention group
Group type: EXPERIMENTAL
Intervention: LAMA + inhaled corticosteroid (tiotropium/budesonide)
Number of subjects: 45
Study 34306265 — intervention group
Group type: EXPERIMENTAL
Intervention: LABA + LAMA (formoterol/tiotropium)
Number of subjects: 45
Study 35032204 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrotuss® (20 ml, three daily doses)
Number of subjects: 50
Study 35032204 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole (20 mg, once daily)
Number of subjects: 50